The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Exicure(NASDAQ:XCUR) 
Exicure, Inc., a clinical-stage biotechnology company, develops therapeutics for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. Its drug candidate includes cavrotolimod (AST-008) that is in a Phase 1b/2 clini...
Website: http://www.exicuretx.com
Founded: 2011
CEO: David Giljohann
Sector: Healthcare
Industry: Biotechnology
Exicure Number of Twitter Followers
Exicure Days Payable Outstanding ttm (DPO)
Exicure Op Cashflow Per Share ttm
Exicure Free Cashflow Per Share ttm
Exicure Cash Per Share ttm
Exicure P/S ratio ttm
Exicure (GAAP) P/E ratio ttm
Exicure P/B ratio ttm
No extra charts and metrics for this ticker.